To make the health insurance cover more customer-centric, a panel constituted by IRDAI has proposed several important changes to the existing health insurance exclusion rules.
In order to make the health insurance cover more customer-centric, a panel constituted by the Insurance Regulatory and Development Authority of India (IRDAI) has proposed several important changes to the existing health insurance exclusion rules.
To address the alarming injury rate in youth footballers in Sweden, the project Injury-Free Children and Adolescents: Towards Better Practice in Swedish Football (FIT project) seeks to fill in the knowledge gaps by bringing biomedical and social science together.
When it comes to preventive care and confidential medical services, parents and their adolescent children actually agree with each other. They both believe that preventive care is important, that adolescents should be provided with opportunities to speak with their doctor, one-on-one, and that some services should be confidential. These findings are reported by University of Illinois at Chicago and their colleagues in the Journal of Adolescent Health.
Diabetic foot ulcers can take up to 150 days to heal. A biomedical engineering team wants to reduce it to 21 days. They're planning to drop the healing time by amplifying what the body already does naturally: build layers of new tissue pumped up by nitric oxide.
Scientists at The Wistar Institute and collaborators have successfully engineered novel DNA-encoded monoclonal antibodies (DMAbs) targeting Zaire Ebolavirus that were effective in preclinical models. Study results, published online in Cell Reports, showed that DMAbs were expressed over a wide window of time and offered complete and long-term protection against lethal virus challenges.
DMAbs may also provide a novel powerful platform for rapid screening of monoclonal antibodies enhancing preclinical development. The Weiner Laboratory is also developing an anti-Ebola virus DNA vaccine. Preclinical results from this were published recently in the Journal of Infectious Diseases .
HIV, the virus that causes AIDS, has been studied extensively ever since the AIDS epidemic was officially recognized by health professionals in the early 1980s. During that time, research has led to the development of effective antiretroviral drugs that in many cases prevent an HIV-infected person from developing AIDS.
The influenza virus can evolve resistance to an anti-flu drug currently in development for use in pandemics but only if there are multiple genetic mutations, a study has found. Scientists at Imperial College London, in collaboration with Public Health England, have discovered that two genetic mutations would be needed for the virus to develop resistance to favipiravir, an experimental antiviral developed in Japan.
Researchers have evidence that Kawasaki Disease (KD) does not have a single cause. By studying weather patterns and geographic distributions of patients in San Diego, the research team determined that this disease has influenced multiple environmental triggers by a combination of temperature, precipitation and wind patterns.
A research team describes a newly discovered mechanism. The findings shed new light on our immune systems – and also pave the way for drug delivery techniques to be developed that harness this natural transportation process from one group of cells to another.
Researchers have found that the anti-parasite drug benznidazole may improve the long-term prognoses of patients with chronic Chagas disease, according to a study published in PLOS Neglected Tropical Diseases , by Clareci Silva Cardoso at the Federal University of São João del-Rei, Divinópolis, Brazil, and colleagues from the SaMi-Trop study, a project funded by NIAID / NIH.
Southampton researcher, Dr. Michael Head, is calling for immediate action to tackle pneumonia after a new report named the condition as the leading disease in the killer in the world, claiming an estimated 2.6 million lives in 2017
Scientists at the UCLA Jonsson Comprehensive Cancer Center have identified sodium glucose transporter 2, or SGLT2, as a mechanism that lung cancer cells use to obtain glucose, which is key to their survival and promotes tumor growth. The finding provides evidence that SGLT2 may be a novel biomarker that scientists can use to help diagnose precancerous lung lesions and early-stage lung cancers.